AbbVie Reports Third-Quarter 2026 Financial Results - AbbVie News Center
Source: AbbVie News Center ·
AbbVie Reports Third-Quarter 2026 Financial Results AbbVie News CenterAbbVie Revenue Rises on Strength in Immunology, Neuroscience WSJAbbVie beats estimates but stock dips Yahoo FinanceAbbVie lifts annual profit forecast as immunology drugs continue to fuel growth ReutersAbbVie’s earnings double as drugmaker eyes a move into obesity treatments Crain's Chicago Business
From the source
- EnglishUnited States - Deutsch - English - Español - Français - Italiano - All languages - Afrikaans - azərbaycan - bosanski - català - Čeština - Cymraeg - Dansk - Deutsch - eesti - EnglishUnited Kingdom - EspañolEspaña - EspañolLatinoamérica - euskara - Filipino - FrançaisCanada - FrançaisFrance - Gaeilge - galego - Hrvatski - Indonesia - isiZulu - íslenska - Italiano - Kiswahili - latviešu - lietuvių - magyar - Melayu - Nederlands - norsk - o‘zbek - polski - PortuguêsBrasil - PortuguêsPortugal - română - shqip - Slovenčina - slovenščina - srpski (latinica) - Suomi - Svenska - Tiếng Việt - Türkçe - Ελληνικά - беларуская - български - кыргызча - қазақ тілі - македонски - монгол - Русский - српски - Українська - ქართული - հայերեն - עברית - اردو - العربية - فارسی - አማርኛ - नेपाली - मराठी - हिन्दी - অসমীয়া - বাংলা - ਪੰਜਾਬੀ - ગુજરાતી - ଓଡ଼ିଆ - தமிழ் - తెలుగు - ಕನ್ನಡ - മലയാളം - සිංහල - ไทย - ລາວ - မြန်မာ - ខ្មែរ - 한국어 - 日本語 - 简体中文 - 繁體中文 - 繁體中文香港 - EnglishUnited States - Deutsch -…